Advanced Search:
Equity Index

BIM.PA - BIOMERIEUX

€102.25  1.05 (1.04%)

Updated: 11:45 May 5, 2024 EST

Next Session's AI Forecast

96.6%

Avg. Accuracy (AI)

€103.86

Next Week's AI Forecast

0%

Trend's Accuracy (AI)

€104.91

BIOMERIEUX's Position Within the Diagnostics & Research Industry
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)
0 (Bottom)
100 (Top) Data Normalization
Rank (0-100)

BIOMERIEUX - HISTORICAL DATA 6M

  • Last price

    €102.25

  • Daily change

    €1.05

  • Previous Close

    €101.2

  • Last Updated

    11:45 May 5, 2024 EST

CURRENT VOLATILITY

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
-0.05 0.11 -0.01 0.06 0.04

CURRENT VOLATILITY RANK

Variation from the lowest to the highest value in a period.

Curr. Week Curr. Month Curr. Quarter Next Quarter Curr Year
0.61 1.48 1.15 1.1 1.16

STOCHASTIC METRIC

The STOCHASTIC METRIC shows when a financial asset has moved into an overbought or oversold position.

OVERSOLD
OVERBOUGHT
Curr. Week Next Week Curr. Month Curr. Quarter
100% 30.56% 14.67% 42.34%

MOVING AVERAGE METRIC

5 Sessions Change 5 Sessions 20 Sessions Change 20 Sessions 50 Sessions Change 50 Sessions 200 Sessions
99.6 -0.6% 100.2 -0.5% 100.7 1.45% 99.26

RSI METRIC

RS Hour RSI Hour RS Day RSI Day
1.39 96.88 0.79 58.16

BIOMERIEUX Technical Analysis News

BIOMERIEUX

376 Chemin De l’Orme
Marcy-l'Étoile 69280
France
33 4 78 87 20 00
https://www.biomerieux.com

Sectors: Healthcare
Industry: Diagnostics & Research
F. Time Employees: 13409
Description

bioMérieux S.A. develops and produces in vitro diagnostic solutions for the diagnosis of infectious diseases in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company offers systems that use biological samples, such as blood, saliva, urine, etc. for the diagnosis of infectious diseases, including bacterial infections, parasitic infections, and viral infections; and microbiological control of production or the production environment primarily for food, pharmaceutical, and cosmetic industries. It also provides a suite of software products and services that collect, analyze, and merge various sources of data to make decisions under the BIOMÉRIEUX VISION SUITE name; designs, manufactures, and maintains instruments and software; and designs and manufactures reagents for in vitro diagnostic tests. The company serves clinical and hospital laboratories, physicians, blood banks, vets, and industrial control laboratories. bioMérieux S.A. was formerly known as B-D Mérieux. The company was founded in 1963 and is headquartered in Marcy-l'Étoile, France. bioMérieux S.A. is a subsidiary of Institut Mérieux SA.

Corporate Governance

bioMérieux S.A.’s ISS Governance QualityScore as of May 1, 2024 is 9. The pillar scores are Audit: 5; Board: 8; Shareholder Rights: 8; Compensation: 10.

BIOMERIEUX'S HOLDERS RANK

List of holders with stock participation in BIOMERIEUX.

Holder Rank Holder Shares Date Reported % Out Value